
Loading, please wait...

Loading, please wait...

To start, the Fontan procedure serves as the definitive final stage for single-ventricle palliation. However, achieving Fontan procedure candidacy is not always a guaranteed outcome for every child. Therefore, a 10-year report recently analyzed why some patients experience attrition following their stage 2 surgery. Initially, researchers included 427 patients who underwent superior cavopulmonary anastomosis at a single institution. Notably, 93% of these patients successfully reached the Fontan stage or received a referral for it. In contrast, 31 patients became non-candidates due to various clinical complications.
Specifically, cardiac reasons accounted for 26 of these non-candidacy cases. For example, univentricular dysfunction and severe atrioventricular valve regurgitation were the primary limiting factors. In addition, respiratory conditions prevented progression in three patients, while miscellaneous reasons affected two others. Furthermore, outcomes differed significantly based on the underlying reason for attrition. Specifically, patients with respiratory or miscellaneous issues remained alive without further surgical palliation during the study. Conversely, cardiac non-candidates faced much poorer prognoses. In fact, 55% of them eventually required a heart transplant or were added to the waitlist.
As a result, cardiac health remains the most critical factor for maintaining Fontan procedure candidacy. Moreover, predicting this candidacy before the second stage of surgery remains a significant challenge for clinicians. Similarly, researchers found that a higher incidence of moderate or severe valve regurgitation before stage 2 was a major risk factor. Consequently, early and rigorous echocardiographic screening is essential for identifying patients at risk of attrition. Ultimately, these findings highlight the complex physiological demands required to complete the single-ventricle surgical pathway.
Cardiac issues, specifically univentricular dysfunction and significant atrioventricular valve regurgitation, are the leading causes. Respiratory concerns and miscellaneous health conditions contribute to a smaller percentage of cases.
Yes, many patients disqualified for non-cardiac reasons remain alive without further surgical palliation. However, those with cardiac-related non-candidacy often have a higher risk of heart failure and may require a heart transplant.
Moderate or severe atrioventricular valve regurgitation prior to the superior cavopulmonary anastomosis is a significant predictor of attrition. Early detection of these markers through echocardiography is vital for long-term planning.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A 10-year report on Fontan procedure attrition, highlighting cardiac dysfunction and respiratory health as key factors in single-ventricle patient care....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today